Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

ACTI

Actividentity Corp (MM) (ACTI)

Actividentity Corp (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACTI
DateHeureSourceTitreSymboleSociété
23/05/201920h00GlobeNewswireAnnual General Meeting of Active Biotech ABNASDAQ:ACTIActividentity Corp (MM)
03/05/201913h00GlobeNewswireThe Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "American Ac...NASDAQ:ACTIActividentity Corp (MM)
02/05/201913h00GlobeNewswireThe Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksel...NASDAQ:ACTIActividentity Corp (MM)
26/04/201911h00GlobeNewswireAnnual Report 2018 Active Biotech AB (publ)NASDAQ:ACTIActividentity Corp (MM)
25/04/201908h30GlobeNewswireActive Biotech AB - Interim report January - March 2019NASDAQ:ACTIActividentity Corp (MM)
24/04/201913h00GlobeNewswireActive Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:ACTIActividentity Corp (MM)
05/04/201914h15GlobeNewswireActive Biotech completes sale of propertyNASDAQ:ACTIActividentity Corp (MM)
04/04/201918h00GlobeNewswireExtraordinary General Meeting of Active Biotech ABNASDAQ:ACTIActividentity Corp (MM)
13/03/201918h15GlobeNewswireNOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)NASDAQ:ACTIActividentity Corp (MM)
13/03/201918h00GlobeNewswireActive Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on Apri...NASDAQ:ACTIActividentity Corp (MM)
14/02/201908h30GlobeNewswireActive Biotech Year-end report January - December 2018NASDAQ:ACTIActividentity Corp (MM)
11/02/201914h00GlobeNewswireActive Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI...NASDAQ:ACTIActividentity Corp (MM)
01/02/201916h15GlobeNewswireActive Biotech has received an indicative bid for the property in Lund - the Board is positiveNASDAQ:ACTIActividentity Corp (MM)
10/12/201812h30GlobeNewswireActive Biotech provides updated information about the company's financial positionNASDAQ:ACTIActividentity Corp (MM)
19/11/201808h30GlobeNewswireActive Biotech's election committee appointedNASDAQ:ACTIActividentity Corp (MM)
14/11/201821h30GlobeNewswireActive Biotech AB - Interim report January - September 2018NASDAQ:ACTIActividentity Corp (MM)
08/11/201813h00GlobeNewswireActive Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018NASDAQ:ACTIActividentity Corp (MM)
13/09/201811h00GlobeNewswireActive Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Hu...NASDAQ:ACTIActividentity Corp (MM)
05/09/201808h30GlobeNewswireActive Biotech regains global rights to development and commercialization of laquinimodNASDAQ:ACTIActividentity Corp (MM)
09/08/201808h30GlobeNewswireActive Biotech AB - Interim Report January - June 2018NASDAQ:ACTIActividentity Corp (MM)
31/07/201809h15GlobeNewswireActive Biotech provides update on laquinimod in Huntington's diseaseNASDAQ:ACTIActividentity Corp (MM)
31/05/201808h30GlobeNewswireNumber of shares and votes in Active BiotechNASDAQ:ACTIActividentity Corp (MM)
17/05/201816h00GlobeNewswireActive Biotech AB Interim report January - March 2018NASDAQ:ACTIActividentity Corp (MM)
23/04/201811h30GlobeNewswireAnnual Report 2017 Active Biotech AB (publ)NASDAQ:ACTIActividentity Corp (MM)
18/04/201816h10GlobeNewswireActive Biotech: Notice of Annual General Meeting of ShareholdersNASDAQ:ACTIActividentity Corp (MM)
16/04/201812h40GlobeNewswireActive Biotech's rights issue over subscribedNASDAQ:ACTIActividentity Corp (MM)
12/04/201813h00GlobeNewswireActive Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blocka...NASDAQ:ACTIActividentity Corp (MM)
27/03/201809h39GlobeNewswireProspectus relating to Active Biotech's rights issue publishedNASDAQ:ACTIActividentity Corp (MM)
15/02/201810h10GlobeNewswireActive Biotech announces rights issue of approximately SEK 48 millionNASDAQ:ACTIActividentity Corp (MM)
15/02/201808h40GlobeNewswireNOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETINGNASDAQ:ACTIActividentity Corp (MM)
 Showing the most relevant articles for your search:NASDAQ:ACTI

Dernières Valeurs Consultées